FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Greene

Research Profile

Physiology

Genes & Molecular Sequences

Disorders

Concepts & Ideas

Procedures

Genetic Testing

Activities & Behaviors

Co-author Network

Publications

TOP 3
Mark E Sherman; Nicolas Wentzensen; Hannah P Yang; Richard Guido; Phuong L Mai; Mark H Greene
New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future research.
Phuong L Mai; David Malkin; Von Means; Simona Ognjanovic; Andrea Farkas Patenaude; June A Peters; Maria Isabel Achatz; Eveline Bleiker; Phillip A Dennis; D Gareth Evans; James Ford; Joseph F Fraumeni; Thierry Frebourg; Judy E Garber; Mark H Greene; Pierre Hainaut; PAUL HWANG; Luana Locke; Joshua D Schiffman; Katherine Schneider; Louise C Strong; Uri Tabori; Jeffrey N Weitzel; Ingrid M Wentzensen; Benjamin Wilfond; Oliver Wyss; Sharon A Savage
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium.
Ying Gao; Barry Graubard; Mark H Greene; Richard B Hayes; Hormuzd Katki; Michael Martin; Michael Pollak; Robert E Schoen; Yuzhen Tao; Timothy Church; Sonja I Berndt
Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Greene (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Mark E Sherman; Nicolas Wentzensen; Hannah P Yang; Richard Guido; Phuong L Mai; Mark H Greene
New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future research.
Gynecologic oncology 2012;127(3):645-50.
2012: Phuong L Mai; David Malkin; Von Means; Simona Ognjanovic; Andrea Farkas Patenaude; June A Peters; Maria Isabel Achatz; Eveline Bleiker; Phillip A Dennis; D Gareth Evans; James Ford; Joseph F Fraumeni; Thierry Frebourg; Judy E Garber; Mark H Greene; Pierre Hainaut; PAUL HWANG; Luana Locke; Joshua D Schiffman; Katherine Schneider; Louise C Strong; Uri Tabori; Jeffrey N Weitzel; Ingrid M Wentzensen; Benjamin Wilfond; Oliver Wyss; Sharon A Savage
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium.
Cancer genetics 2012;205(10):479-87.
2012: Ying Gao; Barry Graubard; Mark H Greene; Richard B Hayes; Hormuzd Katki; Michael Martin; Michael Pollak; Robert E Schoen; Yuzhen Tao; Timothy Church; Sonja I Berndt
Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.
International journal of cancer. Journal international du cancer 2012;131(2):E105-13.
2012: Ju-Hyun Park; Mitchell H Gail; Mark H Greene; Nilanjan Chatterjee
Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(17):2157-62.
2012: Lindsey M Hoskins; Kevin M Roy; Mark H Greene
Toward a new understanding of risk perception among young female BRCA1/2 "previvors".
Families, systems & health : the journal of collaborative family healthcare 2012;30(1):32-46.
2012: Lisa Mirabello; Sharon A Savage; Christian P Kratz; Mark H Greene
Promoter methylation of candidate genes associated with familial testicular cancer.
International journal of molecular epidemiology and genetics 2012;3(3):213-27.
2012: June A Peters; Gladys M Glenn; Lindsey M Hoskins; Regina Kenen; Christian Kratz; Mark H Greene
Close ties: an exploratory Colored Eco-Genetic Relationship Map (CEGRM) study of social connections of men in Familial Testicular Cancer (FTC) families.
Hereditary cancer in clinical practice 2012;10():2.
2011: Suhwan Chang; Chu-Xia Deng; Mark H Greene; Diana C Haines; Claudine Isaacs; Kyung-Ae Kim; Lai M Looi; Phuong Mai; Betty K Martin; Kein S Mun; Elizabeth Poggi; Keiko Akagi; Mark Basik; Stephen W Byers; Luca Cavallone; Soo H Teo; Rui-Hong Wang; Shyam K Sharan
Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155.
Nature medicine 2011;17(10):1275-82.
2011: June A Peters; Barry Graubard; Lindsey M Hoskins; Regina Kenen; Laura M Koehly; Jennifer T Loud; Mark H Greene
Unpacking the blockers: understanding perceptions and social constraints of health communication in hereditary breast ovarian cancer (HBOC) susceptibility families.
Journal of genetic counseling 2011;20(5):450-64.
2011: C P Kratz; Gennady Bratslavsky; Mark H Greene; J Shi
A stratified genetic risk assessment for testicular cancer.
International journal of andrology 2011;34(4 Pt 2):e98-102.
2011: Christian P Kratz; Phuong L Mai; Ruth Pfeiffer; Philip S Rosenberg; Meredith Yeager; Sonja I Berndt; Laurie Burdett; Summer S Han; Larissa A Korde; Mark H Greene
Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour.
Journal of medical genetics 2011;48(7):473-6.
2011: Phuong L Mai; Anne O Garceau; Barry I Graubard; Marsha Dunn; Timothy S McNeel; Lou Gonsalves; Mitchell H Gail; Mark H Greene; Gordon B Willis; Louise Wideroff
Confirmation of family cancer history reported in a population-based survey.
Journal of the National Cancer Institute 2011;103(10):788-97.
2011: Mark H Greene; Phuong L Mai; Peter E Schwartz
Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?
American journal of obstetrics and gynecology 2011;204(1):19.e1-6.
2010: Gretchen L Gierach; Jennifer T Loud; Catherine K Chow; Sheila A Prindiville; Jennifer Eng-Wong; Peter Soballe; Claudia Giambartolomei; Phuong L Mai; Claudia E Galbo; Kathryn Nichols; Kathleen A Calzone; Celine Vachon; Mitchell H Gail; Mark H Greene
Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer.
Breast cancer research and treatment 2010;123(1):245-55.
2010: BLANCHE ALTER; Neelam Giri; Sharon A Savage; June A Peters; Jennifer T Loud; Lisa Leathwood; Ann G Carr; Mark H Greene; Philip S Rosenberg
Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.
British journal of haematology 2010;150(2):179-88.
2010: Christian P Kratz; Phuong L Mai; Mark H Greene
Familial testicular germ cell tumours.
Best practice & research. Clinical endocrinology & metabolism 2010;24(3):503-13.
2010: Mark H Greene; Christian P Kratz; Phuong L Mai; Christine Mueller; June A Peters; Gennady Bratslavsky; Alex Ling; Peter M Choyke; Ahalya Premkumar; Janet Bracci; Rissah J Watkins; Mary Lou McMaster; Larissa A Korde
Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype.
Endocrine-related cancer 2010;17(2):R109-21.
2010: Barbara K Dunn; Mark H Greene; Ying Hu; Neely Kazerouni; Jenny M Kelley; Daoud M Meerzaman; Philip S Rosenberg; Gong Tang; Robert J Clifford; Joseph P Costantino; Kenneth H Buetow
Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention Trial.
International journal of molecular epidemiology and genetics 2010;1(4):332-49.
2010: Lisa Mirabello; Sharon A Savage; Larissa Korde; Shahinaz Gadalla; Mark H Greene
LINE-1 methylation is inherited in familial testicular cancer kindreds.
BMC medical genetics 2010;11():77.
2009: Laura M Koehly; June A Peters; Regina Kenen; Lindsey M Hoskins; Anne L Ersig; Natalia R Kuhn; Jennifer T Loud; Mark H Greene
Characteristics of health information gatherers, disseminators, and blockers within families at risk of hereditary cancer: implications for family health communication interventions.
American journal of public health 2009;99(12):2203-9.
2009: Christine M Mueller; James E Hilbert; William Martens; Charles A Thornton; Richard T Moxley; Mark H Greene
Hypothesis: neoplasms in myotonic dystrophy.
Cancer causes & control : CCC 2009;20(10):2009-20.
2009: M B Cook; Alice J Sigurdson; Irene M Jones; Cynthia B Thomas; Barry I Graubard; L Korde; Mark H Greene; Katherine A McGlynn
Endogenous DNA damage and testicular germ cell tumors.
International journal of andrology 2009;32(6):599-606.
2009: Sharon A Savage; Inderjeet Dokal; Mary Armanios; Geraldine Aubert; Edward W Cowen; Demetrio L Domingo; Neelam Giri; Mark H Greene; Paul J Orchard; Jakub Tolar; Ekaterini Tsilou; Carter Van Waes; Judy M Y Wong; Neal S Young; BLANCHE ALTER
Dyskeratosis congenita: the first NIH clinical research workshop.
Pediatric blood & cancer 2009;53(3):520-3.
2009: Claudia Giambartolomei; Christine M Mueller; Mark H Greene; Larissa A Korde
A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome.
Cancer epidemiology 2009;33(1):31-6.
2009: Jennifer T Loud; Anne C M Thiébaut; Andrea D Abati; Armando C Filie; Kathryn Nichols; David Danforth; Ruthann Giusti; Sheila A Prindiville; Mark H Greene
Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer?
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(4):1243-51.
2009: Mark H Greene; Phuong L Mai
What have we learned from risk-reducing salpingo-oophorectomy?
Journal of the National Cancer Institute 2009;101(2):70-1.
2009: Phuong L Mai; Bingshu E Chen; Kathy Tucker; Michael Friedlander; Kelly-Anne Phillips; David Hogg; Michael A S Jewett; Istvan Bodrogi; Lajos Geczi; Edith Olah; Ketil Heimdal; Sophie D Fosså; Katherine L Nathanson; Larissa Korde; Douglas F Easton; Darshna Dudakia; Robert Huddart; Michael R Stratton; D Timothy Bishop; Elizabeth A Rapley; Mark H Greene
Younger age-at-diagnosis for familial malignant testicular germ cell tumor.
Familial cancer 2009;8(4):451-6.
2009: Jennifer T Loud; Ellen Beckjord; Kathryn Nichols; June Peters; Ruthann Giusti; Mark H Greene
Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancer.
BMC women's health 2009;9():20.
2009: Susan T Vadaparampil; Richard P Moser; Jennifer Loud; June A Peters; Mark H Greene; Larissa Korde
Factors associated with testicular self-examination among unaffected men from multiple-case testicular cancer families.
Hereditary cancer in clinical practice 2009;7(1):11.
2008: Christine M Mueller; Neil Caporaso; Mark H Greene
Familial and genetic risk of transitional cell carcinoma of the urinary tract.
Urologic oncology 2008;26(5):451-64.
2008: June A Peters; Ellen Beckjord; Deliya R Banda Ryan; Ann G Carr; Susan T Vadaparampil; Jennifer T Loud; Larissa Korde; Mark H Greene
Testicular cancer and genetics knowledge among familial testicular cancer family members.
Journal of genetic counseling 2008;17(4):351-64.
2008: Bingshu E Chen; Joan L Kramer; Mark H Greene; Philip S Rosenberg
Competing risks analysis of correlated failure time data.
Biometrics 2008;64(1):172-9.
2008: Christine M Mueller; Phuong L Mai; Jaime Bucher; June A Peters; Jennifer T Loud; Mark H Greene
Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer.
BMC complementary and alternative medicine 2008;8():17.
2007: Christine M Mueller; Larissa Korde; Hormuzd A Katki; Philip S Rosenberg; June A Peters; Mark H Greene
Constitutional cytogenetic analysis in men with hereditary testicular germ cell tumor: no evidence of disease-related abnormalities.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(12):2791-4.
2007: Hormuzd A Katki; Mitchell H Gail; Mark H Greene
Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families.
The lancet oncology 2007;8(12):1042-3.
2007: Lutécia H Mateus Pereira; Marbin A Pineda; William H Rowe; Libia R Fonseca; Mark H Greene; Kenneth Offit; Nathan Ellis; Jinghui Zhang; ANDREW COLLINS; Jeffery Struewing
The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies.
BMC genetics 2007;8():68.
2007: Phuong L Mai; Larissa Korde; Joan Kramer; June Peters; Christine M Mueller; Susan Pfeiffer; Constantine Straturis; Peter A Pinto; Gennady Bratslavsky; Maria Merino; Peter Choyke; W Marston Linehan; Mark H Greene
A possible new syndrome with growth-hormone secreting pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familial testicular germ cell malignancy: A case report.
Journal of medical case reports 2007;1():9.
2006: June A Peters; Susan T Vadaparampil; Joan Kramer; Richard P Moser; Lori Jo Peterson Court; Jennifer T Loud; Mark H Greene
Familial testicular cancer: interest in genetic testing among high-risk family members.
Genetics in medicine : official journal of the American College of Medical Genetics 2006;8(12):760-70.
2006: June A Peters; Lindsey Hoskins; Sheila A Prindiville; Regina Kenen; Mark H Greene
Evolution of the colored eco-genetic relationship map (CEGRM) for assessing social functioning in women in hereditary breast-ovarian (HBOC) families.
Journal of genetic counseling 2006;15(6):477-89.
2006: James V Lacey; Mark H Greene; Saundra S Buys; Douglas Reding; Thomas L Riley; Christine D Berg; Richard M Fagerstrom; Patricia Hartge
Ovarian cancer screening in women with a family history of breast or ovarian cancer.
Obstetrics and gynecology 2006;108(5):1176-84.
2006: Neely Kazerouni; Mark H Greene; James V Lacey; Pamela J Mink; Catherine Schairer
Family history of breast cancer as a risk factor for ovarian cancer in a prospective study.
Cancer 2006;107(5):1075-83.
2006: Jennifer T Loud; Nancy E Weissman; June A Peters; Ruthann M Giusti; Benjamin S Wilfond; Wylie Burke; Mark H Greene
Deliberate deceit of family members: a challenge to providers of clinical genetics services.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(10):1643-6.
2006: Lois B Travis; Charles S Rabkin; Linda Morris Brown; James M Allan; BLANCHE ALTER; Christine B Ambrosone; Colin B Begg; Neil Caporaso; STEPHEN CHANOCK; Angela DeMichele; William Douglas Figg; Mary K Gospodarowicz; Eric J Hall; Michie Hisada; Peter D Inskip; Ruth A Kleinerman; John B Little; David Malkin; Andrea K Ng; Kenneth Offit; Ching-Hon Pui; Leslie L Robison; Nathaniel Rothman; Peter G Shields; Louise Strong; Toshiyasu Taniguchi; Margaret A Tucker; Mark H Greene
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.
Journal of the National Cancer Institute 2006;98(1):15-25.
2006: Amanda B Spurdle; Antonis C Antoniou; Livia Kelemen; Helene Holland; Susan Peock; Margaret R Cook; Paula L Smith; Mark H Greene; Jacques Simard; Marie Plourde; Melissa C Southey; Andrew K Godwin; Jeanne Beck; alexander miron; Mary B Daly; Regina M Santella; John L Hopper; Esther M John; Irene L Andrulis; Francine Durocher; Jeffery Struewing; Douglas F Easton; Georgia Chenevix-Trench
The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(1):76-9.
2006: Andrea Abati; Mark H Greene; Armando C Filie; Jennifer T Loud; Sheila A Prindiville; David N Danforth; Ruthann M Giusti
Quantification of the cellular components of breast duct lavage samples.
Diagnostic cytopathology 2006;34(1):78-81.
2005: Joan L Kramer; Isela Velazquez; Bingshu E Chen; Philip S Rosenberg; Jeffery Struewing; Mark H Greene
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8629-35.
2005: Saundra S Buys; Edward E Partridge; Mark H Greene; Philip C Prorok; Douglas Reding; Thomas L Riley; Patricia Hartge; Richard M Fagerstrom; Lawrence R Ragard; David Chia; Grant Izmirlian; Mona N Fouad; Christine Cole Johnson; John K Gohagan
Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.
American journal of obstetrics and gynecology 2005;193(5):1630-9.
2005: Louise Wideroff; Susan T Vadaparampil; Mark H Greene; Stephen H Taplin; Lorayn Olson; Andrew N Freedman
Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.
Journal of medical genetics 2005;42(10):749-55.
2004: Sholom Wacholder; Jeffery Struewing; Patricia Hartge; Mark H Greene; Margaret A Tucker
Breast cancer risks for BRCA1/2 carriers.
Science (New York, N.Y.) 2004;306(5705):2187-91; author reply 2187-91.
2004: Lutécia H Mateus Pereira; Alice J Sigurdson; Michele Morin Doody; Marbin A Pineda; Bruce H Alexander; Mark H Greene; Jeffery Struewing
CHEK2:1100delC and female breast cancer in the United States.
International journal of cancer. Journal international du cancer 2004;112(3):541-3.
2004: June A Peters; Regina Kenen; Ruthann M Giusti; Jennifer T Loud; Nancy Weissman; Mark H Greene
Exploratory study of the feasibility and utility of the colored eco-genetic relationship map (CEGRM) in women at high genetic risk of developing breast cancer.
American journal of medical genetics. Part A 2004;130A(3):258-64.
2004: Jeffery Struewing; Patricia Hartge; Sholom Wacholder; Margaret A Tucker; Mark H Greene
BRCA1 and sex ratio.
European journal of human genetics : EJHG 2004;12(8):663-7.
2003: Ruthann M Giusti; Joni L Rutter; P H Duray; L S Freedman; M Konichezky; J Fisher-Fischbein; Mark H Greene; B Maslansky; Alf Fischbein; Stephen B Gruber; G Rennert; R D Ronchetti; S M Hewitt; Jeffery Struewing; Jose Iscovich
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.
Journal of medical genetics 2003;40(10):787-92.
2003: Joni L Rutter; Amelia M Smith; Michael R Dávila; Alice J Sigurdson; Ruthann M Giusti; Marbin A Pineda; Michele Morin Doody; Margaret A Tucker; Mark H Greene; Jinghui Zhang; Jeffery Struewing
Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Human mutation 2003;22(2):121-8.
2003: BLANCHE ALTER; Mark H Greene; Isela Velazquez; Philip S Rosenberg
Cancer in Fanconi anemia.
Blood 2003;101(5):2072.
2003: Philip S Rosenberg; Mark H Greene; BLANCHE ALTER
Cancer incidence in persons with Fanconi anemia.
Blood 2003;101(3):822-6.
2002: Neely Kazerouni; C Schairer; H B Friedman; James V Lacey; Mark H Greene
Family history of breast cancer as a determinant of the risk of developing endometrial cancer: a nationwide cohort study.
Journal of medical genetics 2002;39(11):826-32.
2001: Michie Hisada; Robert J Biggar; Mark H Greene; Joseph Fraumeni; Lois B Travis
Solid tumors after chronic lymphocytic leukemia.
Blood 2001;98(6):1979-81.